regadenoson has been researched along with paclitaxel in 2 studies
Studies (regadenoson) | Trials (regadenoson) | Recent Studies (post-2010) (regadenoson) | Studies (paclitaxel) | Trials (paclitaxel) | Recent Studies (post-2010) (paclitaxel) |
---|---|---|---|---|---|
321 | 53 | 264 | 31,874 | 5,729 | 15,395 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Cai, Q; Carson, RE; Gao, X; Grutzendler, J; Han, L; Holden, D; Huang, Y; Kong, DK; Li, L; Ma, C; Murikinati, S; Park, JH; Piepmeier, JM; Thomas, JL; Tian, D; Ye, C; Yuan, P; Zheng, MQ; Zhou, J | 1 |
1 review(s) available for regadenoson and paclitaxel
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for regadenoson and paclitaxel
Article | Year |
---|---|
Increased Nanoparticle Delivery to Brain Tumors by Autocatalytic Priming for Improved Treatment and Imaging.
Topics: Animals; Antineoplastic Agents; Biological Transport; Blood-Brain Barrier; Brain Neoplasms; Cell Line, Tumor; Decanoic Acids; Drug Delivery Systems; Ethanolamines; Female; Genetic Therapy; Heterografts; Humans; Matrix Metalloproteinase 2; Mice; Mice, Inbred C57BL; Nanoparticles; Optical Imaging; Paclitaxel; Permeability; Polymers; Purines; Pyrazoles; Scorpion Venoms; Transcytosis; Tumor Microenvironment | 2016 |